Q-omics provides the consensus-scored KRTAP13-6P profile across patient tissues and cancer cell-line models. KRTAP13-6P expression is associated with patient survival in 10 of 34 cancer types, with the highest sampling consensus in LIHC. Additionally, KRTAP13-6P RNA expression shows 6,025 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight LIHC, and STAD as cancer lineages where KRTAP13-6P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for KRTAP13-6P — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Survival associations

This table summarizes KRTAP13-6P survival associations across molecular data types. KRTAP13-6P RNA expression shows survival associations in the most cancer types (10). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

KRTAP13-6P data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	10	LIHC (108)	view →

This table ranks reproducible KRTAP13-6P RNA expression–survival associations across cancer types. High KRTAP13-6P expression shows unfavorable associations in LIHC, BLCA, THCA, PAAD and THYM, but favorable associations in STAD. The LIHC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify LIHC as the clearest survival context for KRTAP13-6P RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Tertile	All	0.129	0.707	<.001	108	view →
BLCA	DFS	Tertile	All	0.192	0.619	<.001	99	view →
THCA	OS	Tertile	All	0.575	0.951	<.001	90	view →
STAD	OS	Tertile	IV	1.000	0.271	.014	39	view →
PAAD	OS	Tertile	II,III,IV	0.213	0.556	.014	36	view →
THYM	DFS	Tertile	All	0.075	0.885	<.001	18	view →

Pink = unfavorable, green = favorable. all 10 lineages →

KRTAP13-6P-LIHC (OS)

Kaplan–Meier survival curve for KRTAP13-6P RNA expression in LIHC: high vs low expression groups.

Explore this curve interactively →

Cross-omics associations

This table shows molecular features associated with KRTAP13-6P in patient tissues and cancer cell lines. In patient samples, KRTAP13-6P shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Function (RNA)	6,025	STAD (5905)	view →
RNA	4,280	STAD (1597)	view →